Research and analysis

Shingles immunisation programme [Shingrix®]: evaluation reports

Evaluation of the Shingrix® herpes zoster (shingles) vaccination programme in England: academic year 2023 to 2024.

From:
UK Health Security Agency
Published
29 August 2024
Last updated
26 September 2024 — See all updates

Applies to England

Documents

Shingrix® vaccine uptake report (adults eligible from September 2023 to May 2024 and vaccinated to the end of July 2024): England

Ref: HPR 18(8)

HTML

Shingrix® vaccine coverage by ICB and LA (England), 1 March 2023 to 31 May 2024 (vaccinated to 23 July 2024)

Ref: HPR 18(8)

MS Excel Spreadsheet, 89.6 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Shingrix® vaccine uptake report (adults eligible from September 2023 to February 2024 and vaccinated to the end of April 2024): England

Ref: HPR 18(7)

HTML

Shingrix® vaccine coverage by ICB and LA (England), September 2023 to February 2024 (vaccinated to end-April 2024)

Ref: HPR 18(7)

MS Excel Spreadsheet, 118 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

For reports covering earlier years, when Zostavax® was in use, see Herpes zoster (shingles) immunisation programme 2023 to 2024: evaluation reports.

Updates to this page

Published 29 August 2024
Last updated 26 September 2024 + show all updates

  1. Added quarterly report and data file for Q2 of epidemiological year 2023/24.

  2. First published.

Sign up for emails or print this page

Related content